Gene Query: UBR5

Dataset Description Geneva Score
Genes significantly down or Up-regulated upon RNF219 knockdown 34.85
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 33.61
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 27.55
Cleavage Factor Im as a key regulator of 3’ UTR length 26.61
RNA sequencing of mechanically strained NHEKs and control NHEKs 25.73
XPO1 inhibition antagonizes MCL via nuclear retention of IkB: Selinexor demonstrates antitumor activities in both ibr-sensitive and ibr-resistant tumor cells 24.82
Differetially expressed genes after hTR overexpression in U2OS cells 22.83
High-throughput sequencing of PROMPT-enriched samples. 22.12
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 21.39
Gene expression profile of HGC27 gastric cancer cell p53 KO and KD 21.24
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 20.7
TALENs-mediated gene disruption of FLT3 in leukemia cells: Using genome-editing approach for exploring the molecular basis of gene abnormality 20.45
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 19.71
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 19.62
mRNA expression in human DAOY cells 19.47
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 19.18
RNA transcriptome analysis during HSV-1 infection 19.14
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 18.91
RIG-I and MDA5 fRIP during KSHV lytic reactivation 18.48
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression 18.45
Survival of pancreatic cancer cells lacking KRAS function 18.39
CD95/Fas ligand mRNA is toxic to cells 18.0
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 17.01
Regulation of highly expressed hCINAP on translatome 16.86
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 16.83
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq B-ALL) 16.56
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 16.29
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 16.21
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 16.06
hTERT promotes cell adhesion and migration independent of telomerase activity 15.9
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.86
Impact of dieldrin on transcription in Jurkat T cells 15.54
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 15.34
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 15.21
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 14.99
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 14.99
BET bromodomain proteins function as master transcription elongation factors independent of CDK9 recruitment [NET-seq] 14.97
Transcriptomic characterization of a human in vitro model of arrhythmogenic cardiomyopathy under topological and mechanical stimuli 14.85
Ribosomal footprinting of MDA-Parental and MDA-LM2 14.84
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 14.73
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 14.41
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 14.39
PR isoform-specific ER and PR chromatin binding and gene expression observed in-vitro in breast cancer cells. 14.37
Distinct epigenomes in CD4+ T cells of newborns, middle-ages and centenarians. 14.27
Next Generation Sequencing Facilitates Quantitative Analysis of mesoderm posterior bHLH transcription factor 1(MESP1)+ and MESP1- cells' Transcriptomes 14.23
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 14.21
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages 14.07
Utilizing single-cell variations to reveal environment-dependent tuning of network connectivity in human macrophages (RNA-Seq, CAGE and ChIP-Seq) 14.07
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 14.05
LNCaP treated with iBET 13.95
Global response to chemotherapy-induced apoptosis 13.92
RNA-seq in neutrophils from Juvenile Idiopathic Arthritis 13.8
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 13.79
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 13.64
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 13.64
Human Sandhoff Disease Cerebral Organoids Exhibit Enlarged Size, Increased Cellular Proliferation, and Impaired Differentiation 13.59
3’ Uridylation Expands miRNA Target Repertoire 13.5
HOXC6 affects the malignant phenotype of esophageal squamous cell carcinoma cells 13.47
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 13.42
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 13.42
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 13.34
RNA-Seq analysis of breast cancer cells after shikonin treatment 12.93
ENPP1 Mutation Causes Recessive Cole Disease by Altering Melanogenesis 12.93
Safeguarding nucleolar homeostasis by CBX4 alleviates senescence and osteoarthritis 12.86
Transcriptome profiles of moderate dysplasia in oral mucosa associated with malignant conversion 12.66
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 12.65
12.62
Codon usage optimization in pluripotent embryonic stem cells [tRNA sequencing] 12.51
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 12.44
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 12.22
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 12.21
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress 12.13
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 12.05
An RNA-centric dissection of host complexes controlling flavivirus infection 12.05
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 11.99
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification [Mouse and Human RNA-seq and BS-seq] 11.87
Comparative principles of DNA methylation reprogramming during human and mouse in vitro primordial germ cell specification 11.87
RNA-seq analysis of BAP1-depleted uveal melanoma cells 11.84
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 11.7
SERPINA3- a novel keratinocyte differentiation promotor mediates epidermal barrier repair response in psoriatic lesion 11.65
RNA-seq data for non-targeting siRNA and CDK11 siRNA transfection in SHhES8 cells 11.5
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 11.5
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 11.39
Exercise-induced transcriptome changes in skeletal muscle adapted to aerobic training 11.34
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq 2] 11.18
Insulin receptor associates with promoters genome-wide and regulates gene expression [RNA-seq] 11.15
RNA-SEQ assay for wild type and CRISPR induced endoglin knockout human pulmonary artery smooth muscle cells (PASMC) 11.02
Comparison of single-cell transcriptomics quality between unfixed cells and cells that were fixed and mock stained according to the RAID procedure 10.95
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 10.94
Transcriptome analysis of A549 cells expressing a SUMOylation-deficient TRIM28 mutant in the context of influenza A virus infection 10.88
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 10.62
Active translatome profiling with RiboLace in MCF7 cells 10.61
Total RNA sequencing of WT intestinal orgaonids. 10.61
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 10.6
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines (mRNA-Seq) 10.49
Next Generation Sequencing of Transcriptomes of Cutaneous Melanocytes and Metastatic Melanoma Cell Lines 10.49
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 10.47
Knockdown of FOXP1 promotes the development of lung adenocarcinoma 10.47
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 10.46
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 10.43
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 10.42
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 10.4
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 10.36
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 10.3
RNA-seq of human aneuploid cell lines with Trisomy 21 10.3
Expression profile and potential functions of circulating long noncoding RNAs in acute ischemic stroke in the Southern Chinese Han population 10.28
Disruption of the exocyst induces podocyte loss and dysfunction 10.24
RNA-seq analysis of control and NRDE2-depleted breast cancer cells 10.19
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 10.18
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 10.17
MiR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction [III] 10.09
The transcriptome effect of overexpressing EZH2 in MCF7 10.08
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.04
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 9.97
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 9.97
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 9.94
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 9.94
Transcriptomic Dynamics during Differentiation Process of Human Pluripotent Cells into Hepatocyte-like Cells 9.93
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 9.93
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 9.8
MYC dependent mRNA translation shapes gene expression and cell biology 9.74
CXCR4 is a host factor that regulates Plasmodium development in hepatocytes 9.67
Cell-specific expression and function patterns of microRNA-150-5p in liver fibrogenesis 9.62
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer 9.57
An evolutionarily conserved function of polycomb silences the MHC class I antigen presentation pathway and enables immune evasion in cancer [RNA-Seq] 9.57
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 9.55
Stimulation of isolated plasmacytoid dendritic cells (pDCs) with TLR9 agonist CpG C (CpG) and TLR7 agonist imiquimod (IMQ) 9.55
Regulation of hypoxia-inducible factor activity by ZMYND8 9.41
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 9.38
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 9.35
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 9.33
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 9.24
Role of XRN2 ribonucleolytic activity in RNA metabolism 9.23
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 9.18
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 9.04
Genetic disarray follows mutant KLF1-E325K expression in a congenital dyserythropoietic anemia patient 9.03
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.99
Impact of GDF15 expression of ovarian cancer cell on stroma and Cisplatin responses 8.96
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 8.95
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 8.95
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 8.93
DART-seq: an antibody-free method for global m6A detection 8.93
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 8.93
Whole-Transcriptome Profiling of Canine and Human in Vitro Models Exposed to a G-Quadruplex Binding Small Molecule 8.88
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 8.87
Investigation into human Tra2 protein-dependent splicing in MDA-MB-231 cells using iCLIP and RNA-seq 8.79
The hepatitis C viral protein NS5A stabilizes growth-regulatory human transcripts 8.78
Viral determinants in H5N1 influenza A virus enable productive infection of HeLa cells 8.72
RNAseq Study in CC-671 Treated Cal-51 Cells 8.68
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 8.66
Novel Targeting of Transcription and Metabolism in Glioblastoma 8.64
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 8.55
Potent and targeted activation of HIV-1 using the CRISPR/Cas9 activator Complex 8.49
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 8.43
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 8.33
Chromatin accessibility landscape upon induction of Msgn1, Pax3 and Myf5 in mesodermal cells and identification of conserved Pax3 binding sites and target genes during skeletal myogenesis 8.33
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 8.32
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 8.25
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 8.22
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 8.21
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes 8.13
Exploring the RNA landscape of endothelial exosomes 8.11
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 8.11
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 8.1
Transcriptomic profiles of human foreskin fibroblast cells in response to orf virus 8.08
RNA-seq analysis of AML cells in response to ASLAN003 8.04
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 8.03
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 8.0
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 7.99
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.99
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 7.97
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity 7.96
Comparative Analysis of the Transcriptome of Latent Autoimmune Diabetes (LADA) Patients from Eastern China 7.94
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 7.93
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 7.92
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 7.9
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 7.9
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 7.87
Regulatory network controlling tumor-promoting inflammation in human cancers 7.87
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 7.8
RNA-seq analysis of SKMEL28 melanoma cells following DIRC3 and IGFBP5 ASO knockdown 7.73
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 7.69
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 7.67
Stem and effector CD8 T-cells from human cancers 7.61
Expression data from miR340 overexpressing human A549 cells 7.59
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 7.54
Effect of hyperfractionated irradiation (HFRT) of prostate primary basal cells (PrEPs) on the transcriptome 7.54
Effects on gene expression of doxorubicin in human stem cells-derived cardiomyocytes 7.54
miRNAs affected by antagomiR-17 treatment 7.53
Toxicogenomics of the flame retardant tris (2-butoxyethyl) phosphate in HepG2 cells using RNA-seq. 7.5
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 7.39
Human cell line and subcutaneous tumor 7.35
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 7.34
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 7.34
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 7.25
Molecular Criteria for Defining the Naive Human Pluripotent State 7.22
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 7.2
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with ENST00000431060 shRNA or control shRNA 7.19
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 7.13
snRNAs as regulators of alternative splicing 7.12
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 7.12
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 7.11
Gene expression changes in HSV-1 infected HeLa cells with knockdown of B2M 7.08
NF-κB p65 dimerization and DNA-binding is important for inflammatory gene expression 7.01
Identification of miRNA signatures during the differentiation of hESCs into retinal pigment epithelial cells 6.99
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 6.94
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 6.93
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes (RNA-Seq) 6.85
Membrane Metallo-Endopeptidase (Neprilysin) Regulates Inflammatory Response and Insulin Signaling in White Preadipocytes 6.85
TCF21 and Aryl-hydrocarbon receptor gene cooperate to activate a pro-atherosclerotic gene expression program 6.84
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 6.83
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 6.83
A transcriptome dataset revealing the molecular features of breast cancer stem cells 6.8
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 6.77
RNA sequencing (RNA-SEQ) of Human endothelial cells (HUVEC) in LFS, sFRP2OE, and WT conditioned media 6.73
Transcriptome wide identification of retained introns upon depletion of the splicing factors SNW1 or PRPF8 6.71
KAP1 regulates ERVs in differentiated human cells and contributes to innate immune control 6.69
Genome-wide detection of DNase I hypersensitive sites in single cells and FFPE tissue samples 6.68
Apolipoprotein E4 Expression Causes Gain of Toxic Function in Isogenic Human Induced Pluripotent Stem Cell-Derived Endothelial Cells 6.65
Transcriptomic analysis of the HOTAIR-regulated genes 6.64
SLAM-seq for K562 endogenous mRNA decay 6.62
Global transcriptional profiling changes upon knockdown of G9a in human non-small cell lung cancer cells 6.6
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 6.54
Assessing the effect of SUPT4H1 RNAi on the transcription of a repeat-containing reporter construct 6.51
RNA-sequencing with micro-dissected boundary organoid into anterior, posterior, and boundary regions 6.42
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 6.41
Transcriptome changes due to nuclear penetration of cancer extracellular vesicles 6.36
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.3
MiR-26 dampens IL-6 production by down-regulating TNF-a/NF-kB signaling through silencing HMGA1 and MALT1 and not by directly targeting IL-6 mRNA 6.3
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 6.27
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 6.25
Translocation of dense granule effectors across the parasitophorous vacuole membrane in Toxoplasma-infected cells requires the activity of ROP17, a rhoptry protein kinase 6.19
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 6.18
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 6.18
LINE-2 transposable elements are a source of functional human microRNAs and target sites 6.14
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 6.13
Systematic discovery of endogenous human ribonucleoprotein complexes 6.13
RNA-seq of naive and primed ES cells 6.11
RNAseq of Extracellular vesicle RNAs and cellular RNAs from HPASMCs with or without TGF-b1 or BMP4 treatment 6.09
X-Ray induced DNA-Hydroxymethylation changes 6.05
hiPSCs unravel aberrant TGFβ signaling as an etiology of left ventricular non-compaction 6.03
Mutational landscape of splicing genes and functional consequences across 33 cancer types 5.94
The cohesin release factor WAPL restricts chromatin loop extension. 5.93
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 5.93
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 5.89
Defective structural RNA processing in relapsing-remitting multiple sclerosis 5.87
RNA-seq of shEZH2 cells 5.83
Antibody-Mediated Inhibition of MICA/B Shedding Promotes NK Cell-Driven Tumor Immunity 5.83
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 5.74
Oncogenic changes and EMT in normal human bile duct epithelial cells are caused by parasite-derived materials and N-nitrosodimethylamine 5.63
Pain-driven transcriptome changes in synovium of knee osteoarthritis patients 5.61
PTP4A1 phosphatase is overexpressed in systemic sclerosis fibroblasts and promotes TGFb signaling 5.59
Macrophage Ad5f35 M2 Challenge 5.47
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 5.46
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 5.37
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 5.36
PML2-mediated thread-like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome 5.36
PML2‐mediated thread‐like nuclear bodies mark late senescence in Hutchinson–Gilford progeria syndrome [RNA-seq] 5.36
Allergen-specific immunotherapy modulates the balance of circulating Tfh and Tfr cells 5.36
BBBomics - Human Blood Brain Barrier Transcriptomics Hub [RNA-seq] 5.28
BBBomics - Human Blood Brain Barrier Transcriptomics Hub 5.28
Integrative Genomic and Transcriptomic Analysis Identified Candidate Genes Implicated in the Pathogenesis of Hepatosplenic T-cell Lymphoma 5.2
Hepatosplenic T cell lymphoma 5.2
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 5.19
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 5.16
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 5.16
Postnatal lipids drive hepatocyte maturation 5.11
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 5.08
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 5.08
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 4.99
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 4.86
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 4.84
RNA Sequencing of Human iPS derived Cardiomyocytes 4.82
RNA polymerase in pre-B-ALL cell lines 4.76
NR2F2 study 4.74
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 4.74
METTL3 and WTAP 4.72
The SUMO Pathway as a Therapeutic Option in Pancreatic Cancer 4.71
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 4.7
miR-93 Targets in Human Endothelial Cells 4.67
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 4.56
Microprocessor mediates transcription termination in long noncoding microRNA genes 4.47
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 4.42
Aneuploidy triggers an immune response 4.41
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 4.37
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [GSKJ4_RNA-seq] 4.35
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 4.31
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 4.29
Whole blood RNAseq from Generalised Pustular Psoriasis patients and healthy individuals 4.28
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 4.28
Transcriptome analysis of peripheral blood monocytes 4.2
Landscapes of gene translation in hepatocellular carcinoma tumors revealed by ribosome profiling 4.19
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 4.18
PARP3 is a promoter of chromosomal rearrangements and limits G4 DNA 4.17
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 4.15
Single-cell analysis of human kidney organoids 4.09
Histone H3.1K27 methylation promotes NHEJ by antagonizing FANCD2 on Chromatin 4.07
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 4.05
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 3.97
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 3.97
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 3.92
Global Long Terminal Repeat activation participates in establishing the unique gene expression program of classical Hodgkin Lymphoma [Primary RNA-Seq] 3.91
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 3.83
Copper Regulation of HIF-1 Transcription Activity [RNA-seq] 3.81
Copper Regulation of HIF-1 Transcription Activity 3.81
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 3.72
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 3.71
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 3.7
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 3.63
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 3.59
CDK12 mediated transcriptional regulation in U2OS cells 3.58
UV_24h_GRO-Seq 3.58
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 3.55
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 3.52
RNA-seq of RKO cells with cTAZ KO or putback 3.52
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 3.46
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 3.43
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 3.43
An integrative network biology analysis identifies miR-508-3p as the determinant and a prognosis biomarker of the mesenchymal subtype ovarian cancer 3.41
Recovery and analysis of nascent RNA 3.38
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 3.38
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 3.32
Induction of Cardiomyocyte Proliferation [pz-822_human] 3.24
Regulation of Cell Cycle to Stimulate Adult Cardiomyocyte Proliferation and Cardiac Regeneration 3.24
Impact on erythroid progenitor type on erythroid differntiation 3.19
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.17
Radiation enhances melanoma response to immunotherapeutic and synergizes with benzodiazepines to promote improved anti-tumor activity 3.16
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [mutant MEF2C] 3.12
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 3.07
RNA-seq transcriptonal profiling in human K562 cells with or without dCas9 and sgRNAs 2.97
In situ CAPTURE of chromatin interactions by biotinylated dCas9 2.97
Comparative transcriptome analysis reveals that ECM-Receptor Interaction contributes to the venous metastases of hepatocellular carcinoma 2.93
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 2.9
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 2.86
The mRNA expression analysis of psoriasis skin lesion mesenchymal stem cell 2.86
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 2.86
Differences in miRNA Detection Levels are Technology and Sequence Dependent 2.84
Differences in miRNA Detection Levels are Technology and Sequence Dependent [NGS] 2.84
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 2.84
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 2.72
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 2.72
Metabolism as an early predictor of DPSCs aging 2.71
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 2.71
Multi-omic measurements of heterogeneity in HeLa cells across laboratories 2.68
Microvesicle-mediated delivery of miR-1343: impact on markers of fibrosis 2.67
Peripheral whole blood mRNAs and lncRNAs expression analysis in eosinophilic asthmatics 2.65
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.59
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice [RNA-seq] 2.55
Cistromic re-programming by truncating GATA3 mutations promotes mesenchymal transformation in vitro, but not mammary tumour formation in mice 2.55
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 2.54
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 2.51
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 2.48
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.48
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.48
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 2.47
tRNA modification landscape selectively controls mitochondrial translation efficiency in MERRF 2.45
Disruption of the TFAP2A regulatory domain causes Branchio-Oculo-Facial Syndrome (BOFS) and illuminates pathomechanisms for other human neurocristopathies 2.45
Molecular characterization of gene regulatory networks in primary human tracheal and bronchial epithelial cells. 2.41
WNT signaling memory is required for ACTIVIN to function as a morphogen 2.36
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.29
Exploring ILF2 regulatory genes by next-generation sequencing 2.29
Identification of miR-100 and miR-125b targets by AGO2 RIP-seq and RNA-seq after ectopic expression of miR-100 or miR-125b and evaluation of the TGFb expression signature in PANC-1 cells by RNA-seq 2.27
Comparative Transcriptomics of Triple Negative Breast Cancer Stem Cells and Differentiated Tumor Cells Identifies Teneurin-4 as a Potential Therapeutic Target 2.24
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 2.23
MEF2C phosphorylation is required for chemotherapy resistance in acute myeloid leukemia [inhibitor MRT199665] 2.23
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 2.22
Drug combination of 17-AAG and Belinostat on MDA-MB-231 breast cancer cells 2.21
Argonaute proteins couple chromatin silencing to alternative splicing 2.2
Argonaute proteins couple chromatin silencing to alternative splicing (RNA IP-Seq) 2.2
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.16
Subcellular pathways shared by afflicted patients and mutant mice identify a new drug treatment for aortic aneurysm in Marfan syndrome 2.13
The antineoplastic drug, trastuzumab, dysregulates metabolism in iPSC derived cardiomyocytes. 2.1
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 2.07
Gene expression analysis of human adenomas. 1.92
Transcriptome analysis in a radiosensitive and a radioresistant cell line after ionizing radiation 1.89
Transcriptional repression in hypoxia is mediated by the Sin3A histone deacetylase complex [RNA-seq] 1.86
Human cells contain natural double-stranded RNAs with potential regulatory capacity 1.86
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.85
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.85
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 1.83
EGR1-controlled transcriptome of T HESCs 1.83
ADAR1-editing in HeLa, p150-KO and ADAR1-KO transcriptomes 1.82
ADAR1-editing of cellular and measles virus-derived duplex RNA 1.82
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 1.82
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 1.81
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 1.81
mRNA-Seq profiling of human developing kidney 1.81
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 1.75
Effects of transcription on genome - nuclear lamina interactions: RNA-seq data 1.74
Effects of transcription on genome - nuclear lamina interactions 1.74
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 1.73
RNA-Sequencing data of Varicella Zoster Virus (VZV)-infected human dermal fibroblasts (HDF) 1.68
Comprehensive comparative analysis of 5’ end RNA sequencing methods 1.66
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.66
4sUDRB-seq: measuring transcription elongation and initiation genomewide 1.64
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 1.63
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 1.63
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 1.6
Gene expression changes after LOC550643 silencing 1.59
Identification of renal resident macrophages across species [C1] 1.58
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 1.51
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 1.46
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 1.46
Dynamic gene expression in T-ALL following treatment and release of gamma-secretase inhibition [GRO-Seq] 1.45
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.42
An optimization system for isolating and sequencing of single human colon cancer cells 1.41
A Novel Population of Human Cardiac Resident Mesenchymal Stem Cells 1.35
Exogenous rescue of KLHL9 in SF210 cell line 1.35
Human Treg IFNg/IL-10 subpopulations 1.35
Transposon-based construction of strand-specific RNA-seq libraries 1.35
Genome-wide mapping of TEL-AML1 targets in acute leukemia 1.33
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 1.25
Influenza Vaccination Primes Human Myeloid Cell Cytokine Secretion and Natural Killer Cell Function 1.23
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.23
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.23
KSDM1b Role in Ewing Sarcoma 1.2
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 1.2
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 1.19
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 1.19
A comprehensive gene expression analysis identifies novel immune signatures in cesarean-born infants 1.18
Tricyclic Antidepressants Induce Inactivation of Hepatic Stellate Cell (HSC) Myofibroblasts 1.16
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.14
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 1.14
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 1.13
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 1.11
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 1.08
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.08
Single cell transcriptomics analysis of induced pluripotent stem cell-derived cortical neurons reveals frequent dual layer identity 1.03
Expression of long non-coding RNAs in autoimmunity and linkage to enhancer function and autoimmune disease risk genetic variants 1.0
Tracking transcriptional changes in a species-specific manner during experimental hepatoblastoma progression in vivo 0.98
Transcriptomic analysis of inter- and intra-patient variation in human iPSC cardiomyocytes: Platform for precision medicine to predict drug toxicity 0.91
single cell RNA-seq from GM12878 (ENCSR673UIY) 0.88
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 0.84
MicroRNA Marker Based Prognostication of Oral Squamous Cell Carcinoma 0.83
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 [RNA-Seq] 0.82
An electrical pulse stimulation protocol to study acute epigenetic response to muscle cell contraction uncovers acute hydroxymethylation of the exercise-responsive gene Nr4a3 0.82
The role of the Calcium-Sensing receptor in colorectal cancer 0.81
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 0.8
The control of rRNA synthesis during the directed differentiation of human embryonic stem cells precedes heterochromatin formation. 0.79
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.77
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.77
The role of m6A/m-RNA methylation in stress response regulation 0.75
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.75
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.75
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.75
RNA-Seq of PRMT1 overexpression ECA109 cells 0.7
High-resolution comparative analysis of great ape genomes 0.65
Transcriptional landscape changes during human embryonic stem cell derivation 0.65
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.63
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes 0.61
Global Transcriptome Analysis and Enhancer Landscape of Human Primary T Follicular Helper and T Effector Lymphocytes (RNA-Seq) 0.61
Proximity-CLIP provides a snapshot of occupied cis-acting elements on RNA in different subcellular compartments on a transcriptome-wide scale 0.6
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.59
Identification of a unique gene expression signature in mercury and 2,3,7,8-tetrachlorodibenzo-p-dioxin co-exposed cells 0.58
Ets homologous factor has critical roles in epithelial dysfunction in airway disease 0.55
Ets homologous factor has critical roles in epithelial dysfunction in airway disease [RNA-seq] 0.55
Modulation of nonsense-mediated decay by rapamycin 0.53
4C-seq of insulin promoter, knockdown of INS promoter activity and Genome-wide maps of chromatin state in EndoC-βH1 Cells 0.53
Viral shRNA Knockdown of INS Promotor Activity in EndoC-βH1 Cells  0.53
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 0.49
A code of mono-phosphorylation modulates the function of RB. 0.46
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.44
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.43
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.41
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 0.38
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 0.38
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.37
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 0.35
AUF-1 affected genes in human skin cells 0.35
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.32
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 0.3
Expression analysis of the TAF1 syndrome 0.24
Integrated analysis of MLL-AF9 AML patients and model leukemias highlights RET and other novel therapeutic targets (RNA-seq AML development) 0.21
Human Treg IL-12 stimulation 0.2
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 0.2
Loss of EGFR-DDEF1 signaling in metastatic and unresectable hepatoblastoma 0.18
Distinct and shared functions of ALS-associated TDP-43, FUS, and TAF15 revealed by comprehensive multi-system integrative analyses [RNA-Seq_Stability] 0.17
Cutaneous Immunoprofile of Three Spotted Fever Group Rickettsiosis 0.17
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 0.16
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 0.15
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.13
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.11
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.11
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.11
Kidney compartment specific eQTL studies highlight causal genes and pathways for renal disease development 0.1
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 0.08
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 0.08
Dermal endothelial cells of type 2 diabetic patients 0.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis [RNA-Seq] 0.06
ETS1 induction by the omental microenvironment promotes ovarian cancer metastasis 0.06
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.05
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 0.05
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.05
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 0.05
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 0.04
Concomitant BCORL1 and BRAF mutations in vemurafenib-resistant melanoma cells 0.02
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 0.02
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.01
The secretome of skin cancer cells activates the mTOR/MYC pathway in healthy keratinocytes and converts them into tumorigenic cells 0.01
RNA-sequencing of the brain transcriptome implicates dysregulation of neuroplasticity, circadian rhythms, and GTPase binding in bipolar disorder 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation